Addex Therapeutics Ltd - American Depositary Shares (ADXN)
7.6600
+0.1100 (1.46%)
Addex Therapeutics Ltd is a biopharmaceutical company focused on developing innovative treatments for neurological and psychiatric disorders
The company leverages its expertise in allosteric modulation to identify and develop novel therapies aimed at a variety of conditions, including addiction, anxiety, and epilepsy. By utilizing its proprietary technology platform, Addex works to create safer and more effective therapeutic options that can enhance patient outcomes and address unmet medical needs in the complex field of brain health.
| Previous Close | 7.550 |
|---|---|
| Open | 7.980 |
| Bid | 6.300 |
| Ask | 10.66 |
| Day's Range | 7.660 - 7.980 |
| 52 Week Range | 6.670 - 27.90 |
| Volume | 965 |
| Market Cap | - |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 9,916 |
